Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (231-240 of 355) with videos related to

Pageof 36
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2020
Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studiesAlice D'Onofrio, Lurdes Gano, Rita Melo, et al.
Plos One|April 12, 2011
Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancerPanagiotis A Konstantinopoulos, Stephen A Cannistra, Helen Fountzilas, et al.
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
Cancer Biology & Therapy|December 7, 2007
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancerAntonis Giannakakis, Raphael Sandaltzopoulos, Joel Greshock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2013
TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumorsMark Ibberson, Sylvian Bron, Nicolas Guex, et al.
Nature Chemical Biology|August 19, 2020
Structural dissimilarity from self drives neoepitope escape from immune toleranceJason R Devlin, Jesus A Alonso, Cory M Ayres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancerLin Zhang, Jia Huang, Nuo Yang, et al.
Cancer Research|July 23, 2003
The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Dionyssios Katsaros, et al.
British Journal of Cancer|February 6, 2019
Tumour-reactive T cell subsets in the microenvironment of ovarian cancerMarie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, et al.
NPJ Precision Oncology|August 14, 2024
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroidsDevanjali Dutta, L Francisco Lorenzo-Martín, François Rivest, et al.
Pageof 36

Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2020
Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studiesAlice D'Onofrio, Lurdes Gano, Rita Melo, et al.
Plos One|April 12, 2011
Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancerPanagiotis A Konstantinopoulos, Stephen A Cannistra, Helen Fountzilas, et al.
Journal of Translational Medicine|November 16, 2011
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysateCheryl L-L Chiang, Dawn A Maier, Lana E Kandalaft, et al.
Cancer Biology & Therapy|December 7, 2007
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancerAntonis Giannakakis, Raphael Sandaltzopoulos, Joel Greshock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2013
TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumorsMark Ibberson, Sylvian Bron, Nicolas Guex, et al.
Nature Chemical Biology|August 19, 2020
Structural dissimilarity from self drives neoepitope escape from immune toleranceJason R Devlin, Jesus A Alonso, Cory M Ayres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancerLin Zhang, Jia Huang, Nuo Yang, et al.
Cancer Research|July 23, 2003
The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinomaLin Zhang, Nuo Yang, Dionyssios Katsaros, et al.
British Journal of Cancer|February 6, 2019
Tumour-reactive T cell subsets in the microenvironment of ovarian cancerMarie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, et al.
NPJ Precision Oncology|August 14, 2024
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroidsDevanjali Dutta, L Francisco Lorenzo-Martín, François Rivest, et al.
Pageof 36